Literature DB >> 26284722

Septic Shock: Advances in Diagnosis and Treatment.

Christopher W Seymour1, Matthew R Rosengart2.   

Abstract

IMPORTANCE: Septic shock is a clinical emergency that occurs in more than 230,000 US patients each year. OBSERVATIONS AND ADVANCES: In the setting of suspected or documented infection, septic shock is typically defined in a clinical setting by low systolic (≤90 mm Hg) or mean arterial blood pressure (≤65 mm Hg) accompanied by signs of hypoperfusion (eg, oliguria, hyperlactemia, poor peripheral perfusion, or altered mental status). Focused ultrasonography is recommended for the prompt recognition of complicating physiology (eg, hypovolemia or cardiogenic shock), while invasive hemodynamic monitoring is recommended only for select patients. In septic shock, 3 randomized clinical trials demonstrate that protocolized care offers little advantage compared with management without a protocol. Hydroxyethyl starch is no longer recommended, and debate continues about the role of various crystalloid solutions and albumin. CONCLUSIONS AND RELEVANCE: The prompt diagnosis of septic shock begins with obtainment of medical history and performance of a physical examination for signs and symptoms of infection and may require focused ultrasonography to recognize more complex physiologic manifestations of shock. Clinicians should understand the importance of prompt administration of intravenous fluids and vasoactive medications aimed at restoring adequate circulation, and the limitations of protocol-based therapy, as guided by recent evidence.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284722      PMCID: PMC4646706          DOI: 10.1001/jama.2015.7885

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  72 in total

Review 1.  The ideal crystalloid - what is 'balanced'?

Authors:  Thomas J Morgan
Journal:  Curr Opin Crit Care       Date:  2013-08       Impact factor: 3.687

2.  Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values.

Authors:  Vincent Liu; John W Morehouse; Jay Soule; Alan Whippy; Gabriel J Escobar
Journal:  Ann Am Thorac Soc       Date:  2013-10

3.  An integrated clinico-metabolomic model improves prediction of death in sepsis.

Authors:  Raymond J Langley; Ephraim L Tsalik; Jennifer C van Velkinburgh; Seth W Glickman; Brandon J Rice; Chunping Wang; Bo Chen; Lawrence Carin; Arturo Suarez; Robert P Mohney; Debra H Freeman; Mu Wang; Jinsam You; Jacob Wulff; J Will Thompson; M Arthur Moseley; Stephanie Reisinger; Brian T Edmonds; Brian Grinnell; David R Nelson; Darrell L Dinwiddie; Neil A Miller; Carol J Saunders; Sarah S Soden; Angela J Rogers; Lee Gazourian; Laura E Fredenburgh; Anthony F Massaro; Rebecca M Baron; Augustine M K Choi; G Ralph Corey; Geoffrey S Ginsburg; Charles B Cairns; Ronny M Otero; Vance G Fowler; Emanuel P Rivers; Christopher W Woods; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

4.  Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study.

Authors:  Glenn Hernandez; Alejandro Bruhn; Cecilia Luengo; Tomas Regueira; Eduardo Kattan; Andrea Fuentealba; Jorge Florez; Ricardo Castro; Andres Aquevedo; Ronald Pairumani; Paul McNab; Can Ince
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

5.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

6.  The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.

Authors:  Christopher J L Murray; Charles Atkinson; Kavi Bhalla; Gretchen Birbeck; Roy Burstein; David Chou; Robert Dellavalle; Goodarz Danaei; Majid Ezzati; A Fahimi; D Flaxman; Sherine Gabriel; Emmanuela Gakidou; Nicholas Kassebaum; Shahab Khatibzadeh; Stephen Lim; Steven E Lipshultz; Stephanie London; Michael F MacIntyre; A H Mokdad; A Moran; Andrew E Moran; Dariush Mozaffarian; Tasha Murphy; Moshen Naghavi; C Pope; Thomas Roberts; Joshua Salomon; David C Schwebel; Saeid Shahraz; David A Sleet; Jerry Abraham; Mohammed K Ali; Charles Atkinson; David H Bartels; Kavi Bhalla; Gretchen Birbeck; Roy Burstein; Honglei Chen; Michael H Criqui; Eric L Ding; E Ray Dorsey; Beth E Ebel; Majid Ezzati; S Flaxman; A D Flaxman; Diego Gonzalez-Medina; Bridget Grant; Holly Hagan; Howard Hoffman; Nicholas Kassebaum; Shahab Khatibzadeh; Janet L Leasher; John Lin; Steven E Lipshultz; Rafael Lozano; Yuan Lu; Leslie Mallinger; Mary M McDermott; Renata Micha; Ted R Miller; A A Mokdad; A H Mokdad; Dariush Mozaffarian; Mohsen Naghavi; K M Venkat Narayan; Saad B Omer; Pamela M Pelizzari; David Phillips; Dharani Ranganathan; Frederick P Rivara; Thomas Roberts; Uchechukwu Sampson; Ella Sanman; Amir Sapkota; David C Schwebel; Saeid Sharaz; Rupak Shivakoti; Gitanjali M Singh; David Singh; Mohammad Tavakkoli; Jeffrey A Towbin; James D Wilkinson; Azadeh Zabetian; Jerry Abraham; Mohammad K Ali; Miriam Alvardo; Charles Atkinson; Larry M Baddour; Emelia J Benjamin; Kavi Bhalla; Gretchen Birbeck; Ian Bolliger; Roy Burstein; Emily Carnahan; David Chou; Sumeet S Chugh; Aaron Cohen; K Ellicott Colson; Leslie T Cooper; William Couser; Michael H Criqui; Kaustubh C Dabhadkar; Robert P Dellavalle; Daniel Dicker; E Ray Dorsey; Herbert Duber; Beth E Ebel; Rebecca E Engell; Majid Ezzati; David T Felson; Mariel M Finucane; Seth Flaxman; A D Flaxman; Thomas Fleming; Mohammad H Forouzanfar; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Richard F Gillum; Diego Gonzalez-Medina; Richard Gosselin; Hialy R Gutierrez; Holly Hagan; Rasmus Havmoeller; Howard Hoffman; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayarman; Nicole Johns; Nicholas Kassebaum; Shahab Khatibzadeh; Qing Lan; Janet L Leasher; Stephen Lim; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Leslie Mallinger; Michele Meltzer; George A Mensah; Catherine Michaud; Ted R Miller; Charles Mock; Terrie E Moffitt; A A Mokdad; A H Mokdad; A Moran; Mohsen Naghavi; K M Venkat Narayan; Robert G Nelson; Casey Olives; Saad B Omer; Katrina Ortblad; Bart Ostro; Pamela M Pelizzari; David Phillips; Murugesan Raju; Homie Razavi; Beate Ritz; Thomas Roberts; Ralph L Sacco; Joshua Salomon; Uchechukwu Sampson; David C Schwebel; Saeid Shahraz; Kenji Shibuya; Donald Silberberg; Jasvinder A Singh; Kyle Steenland; Jennifer A Taylor; George D Thurston; Monica S Vavilala; Theo Vos; Gregory R Wagner; Martin A Weinstock; Marc G Weisskopf; Sarah Wulf
Journal:  JAMA       Date:  2013-08-14       Impact factor: 56.272

7.  Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Authors:  Steven M Opal; Pierre-Francois Laterre; Bruno Francois; Steven P LaRosa; Derek C Angus; Jean-Paul Mira; Xavier Wittebole; Thierry Dugernier; Dominique Perrotin; Mark Tidswell; Luis Jauregui; Kenneth Krell; Jan Pachl; Takeshi Takahashi; Claus Peckelsen; Edward Cordasco; Chia-Sheng Chang; Sandra Oeyen; Naoki Aikawa; Tatsuya Maruyama; Roland Schein; Andre C Kalil; Marc Van Nuffelen; Melvyn Lynn; Daniel P Rossignol; Jogadish Gogate; Mary B Roberts; Janice L Wheeler; Jean-Louis Vincent
Journal:  JAMA       Date:  2013-03-20       Impact factor: 56.272

8.  Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe.

Authors:  David T Huang; Derek C Angus; Amber Barnato; Scott R Gunn; John A Kellum; Diana K Stapleton; Lisa A Weissfeld; Donald M Yealy; Sandra L Peake; Anthony Delaney; Rinaldo Bellomo; Peter Cameron; Alisa Higgins; Anna Holdgate; Belinda Howe; Steven A Webb; Patricia Williams; Tiffany M Osborn; Paul R Mouncey; David A Harrison; Sheila E Harvey; Kathryn M Rowan
Journal:  Intensive Care Med       Date:  2013-08-30       Impact factor: 17.440

9.  Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial.

Authors:  Jean-Christophe Richard; Frédérique Bayle; Gael Bourdin; Véronique Leray; Sophie Debord; Bertrand Delannoy; Alina Cividjian Stoian; Florent Wallet; Hodane Yonis; Claude Guerin
Journal:  Crit Care       Date:  2015-01-08       Impact factor: 9.097

Review 10.  Pulmonary artery catheters for adult patients in intensive care.

Authors:  Sujanthy S Rajaram; Nayan K Desai; Ankur Kalra; Mithil Gajera; Susan K Cavanaugh; William Brampton; Duncan Young; Sheila Harvey; Kathy Rowan
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more
  52 in total

1.  [Central venous pressure - a safety parameter].

Authors:  B H Siegler; M Bernhard; T Brenner; H Gerlach; M Henrich; S Hofer; S John; E Kilger; W A Krüger; C Lichtenstern; K Mayer; M Müller; B Niemann; M Oppert; S Rex; R Rossaint; S Weiterer; M A Weigand
Journal:  Anaesthesist       Date:  2015-12       Impact factor: 1.041

2.  Application of a Framework to Assess the Usefulness of Alternative Sepsis Criteria.

Authors:  Christopher W Seymour; Craig M Coopersmith; Clifford S Deutschman; Foster Gesten; Michael Klompas; Mitchell Levy; Gregory S Martin; Tiffany M Osborn; Chanu Rhee; David K Warren; R Scott Watson; Derek C Angus
Journal:  Crit Care Med       Date:  2016-03       Impact factor: 7.598

3.  The Timing of Early Antibiotics and Hospital Mortality in Sepsis.

Authors:  Vincent X Liu; Vikram Fielding-Singh; John D Greene; Jennifer M Baker; Theodore J Iwashyna; Jay Bhattacharya; Gabriel J Escobar
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

4.  Protective effect of isoliquiritigenin against cerebral injury in septic mice via attenuation of NF-κB.

Authors:  Peng Zou; Hong-Ming Ji; Jian-Wei Zhao; Xin-Min Ding; Zi-Gang Zhen; Xuan Zhang; Xiao-Qi Nie; Li-Xiong Xue
Journal:  Inflammopharmacology       Date:  2018-06-26       Impact factor: 4.473

5.  [Intensive care studies from 2015/2016].

Authors:  C J Reuß; M Bernhard; C Beynon; S Hofer; C Jungk; D Michalski; M A Weigand; T Brenner
Journal:  Anaesthesist       Date:  2016-07       Impact factor: 1.041

Review 6.  Current Murine Models of Sepsis.

Authors:  Anthony J Lewis; Christopher W Seymour; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2016-06-15       Impact factor: 2.150

7.  Assessment of method agreement between two minimally invasive hemodynamic measurements in septic shock patients on high doses of vasopressor drugs. A preliminary study.

Authors:  Oana Antal; Mihai Mărginean; Natalia Hagău
Journal:  Rom J Anaesth Intensive Care       Date:  2017-10

8.  Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events.

Authors:  M A Hajebrahimi; S Akbarpour; A Eslami; F Azizi; F Hadaegh
Journal:  J Hum Hypertens       Date:  2017-07-27       Impact factor: 3.012

9.  Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.

Authors:  Peter B Hjortrup; Nicolai Haase; Helle Bundgaard; Simon L Thomsen; Robert Winding; Ville Pettilä; Anne Aaen; David Lodahl; Rasmus E Berthelsen; Henrik Christensen; Martin B Madsen; Per Winkel; Jørn Wetterslev; Anders Perner
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

Review 10.  Bacterial sepsis : Diagnostics and calculated antibiotic therapy.

Authors:  D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Kruger; K Mayer; M W Pletz; D Storzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.